Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations - Wikidata - awgldk - TriplyDB

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

http://www.wikidata.org/entity/Q28282629

about

sameAs

Living with Parkinson's and the Emerging Role of Occupational Therapy Deficits in the Mimicry of Facial Expressions in Parkinson's Disease.A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease Multimodal Swallowing Evaluation with High-Resolution Manometry Reveals Subtle Swallowing Changes in Early and Mid-Stage Parkinson Disease.The Clinical Evaluation of Parkinson's Tremor.Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times Stride segmentation during free walk movements using multi-dimensional subsequence dynamic time warping on inertial sensor data Factors associated with ambulatory activity in de novo Parkinson disease Anticipatory and Compensatory Postural Adjustments in Response to External Lateral Shoulder Perturbations in Subjects with Parkinson's Disease.Assessment of Oropharyngeal Dysphagia in Patients With Parkinson Disease: Use of Ultrasonography.A Validated Smartphone-Based Assessment of Gait and Gait Variability in Parkinson's Disease.Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation.An ERP study of vocal emotion processing in asymmetric Parkinson's disease Random Whole Body Vibration over 5 Weeks Leads to Effects Similar to Placebo: A Controlled Study in Parkinson's Disease.Ultrasonographic (TCS) and clinical findings in overlapping phenotype of essential tremor and Parkinson's disease (ET-PD)Effect of subthalamic deep brain stimulation on turning kinematics and related saccadic eye movements in Parkinson disease A systematic review of biomarkers for disease progression in Parkinson's disease Assessment of Parkinson disease manifestations.Postural and Intention Tremors: A Detailed Clinical Study of Essential Tremor vs. Parkinson's Disease.Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.Deep brain stimulation for movement disorders Standardized handwriting to assess bradykinesia, micrographia and tremor in Parkinson's disease.Plasma DNA Mediate Autonomic Dysfunctions and White Matter Injuries in Patients with Parkinson's Disease A mobile cloud-based Parkinson's disease assessment system for home-based monitoring.Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria.Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.Reliability of functional gait assessment in patients with Parkinson disease: Interrater and intrarater reliability and internal consistency.White matter damage and systemic inflammation in Parkinson's disease.A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease Use of a self-rating scale of the nature and severity of symptoms in Parkinson's Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity.Analysis of four scales for global severity evaluation in Parkinson's disease Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease.Influence of Deep Breathing on Heart Rate Variability in Parkinson's Disease: Co-relation with Severity of Disease and Non-Motor Symptom Scale Score Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.Gait profile score and movement analysis profile in patients with Parkinson's disease during concurrent cognitive load Scalp acupuncture for Parkinson's disease: a systematic review of randomized controlled trials.Upregulation of GPR109A in Parkinson's disease Functional gait assessment and balance evaluation system test: reliability, validity, sensitivity, and specificity for identifying individuals with Parkinson disease who fall Relationship between neural rhythm generation disorders and physical disabilities in Parkinson's disease patients' walking.

P2860

Q26780170-062E9074-C710-48FD-B72D-A867EC1FC0DD Q27304616-171FA087-35D6-4140-AB68-81BEA273B302 Q27311651-38DF0811-0CB1-4353-BB01-5C6CC53B8FA3 Q27315090-D10E0A64-D2B4-401B-AEA8-9F570108E503 Q27333641-E3013F69-82E0-4C5F-B75C-96D331353FE4 Q27333664-AF13ACA7-7E72-4817-9853-9CDDBF9C390D Q28275419-C4F29742-98E1-441B-9CB2-EE4661831F32 Q28647351-25C6C017-E3B9-4A04-9FB0-B818356EB1DA Q29048640-6CA858B4-6C47-4C04-9F47-A6C9EDD1B1EB Q30383792-2D3EE61B-A430-42A2-84F3-574D94339A5A Q30384100-AFC4EC56-B630-4897-B3E0-7D71D95798B1 Q30399320-67758CBC-9D4A-44E1-919B-B6AA2C6C8F8B Q30400127-1A12341A-AB73-431A-BC1E-D2E5FDB0FE5F Q30424399-1B82D568-6DBC-41C8-84BF-281AFA662103 Q30426803-BFA287CE-0951-4F2E-BFAC-54CF75AC309E Q30439600-447E4D8C-36D2-44DF-9D5C-2C4B0920623A Q30451408-9B2B768D-BCFA-451F-B119-ED399C2A5323 Q30455202-9350B9F9-3D19-4660-A746-38A533941585 Q30495302-E944C1E4-666D-4FC1-AAE1-365D0E05F707 Q30539686-A0FFC474-7615-427A-96FE-1284CFB67E0E Q30544056-8B9EA9F4-01B5-4EA3-98A7-CF98F00B07B0 Q30585845-2A2F7F96-4E88-4766-ABB8-36C76729EA7F Q31161591-13C3CEA9-904C-433E-8772-E41F8C09F390 Q33364851-ECE8BD68-A955-4208-B03F-4FB74E587164 Q33443126-69D9C3B2-4315-4452-8D61-B9BB09DD18C7 Q33522059-9F5F438F-2A3A-4462-9452-8D6D0FC626A7 Q33571889-40CE2898-45EE-4BC8-A3DD-6A483CF4B97A Q33590537-460A4CB1-3DDB-4A97-86D2-50C335A75F8F Q33781574-55A6564C-8566-4461-BF0C-A0F107469D02 Q33788172-9310F83D-D62F-4884-BBCA-C5C32D9BF71E Q33807815-FA378E80-5F3F-484B-87C2-6DB0D265094D Q33917305-B8339859-8F74-4D0B-A3DE-8A16C812F830 Q34049272-6CA9DFE3-B4B1-4ECA-B920-79B782DEFE35 Q34108284-619087C5-D91F-4879-9756-114741F265B4 Q34170501-5E436862-6F23-480F-8DF7-35C0C93304B5 Q34280785-5AD3F23F-2123-46CD-A53A-EB1044407840 Q34336418-1DF79430-6589-48AB-8144-7C51FBFC139E Q34361793-28082C96-2D28-46D7-B710-0030EB7625B5 Q34472735-4282E490-C6B2-4C2E-AA5C-57BAAA355762 Q34490127-A77ECC4B-5B02-4191-B997-07EBEA06D333

P2860

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

http://www.wikidata.org/entity/Q28282629

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Movement Disorder Society Task ...... le: status and recommendations

@ast

Movement Disorder Society Task ...... le: status and recommendations

@en

Movement Disorder Society Task ...... le: status and recommendations

@nl

type

label

Movement Disorder Society Task ...... le: status and recommendations

@ast

Movement Disorder Society Task ...... le: status and recommendations

@en

Movement Disorder Society Task ...... le: status and recommendations

@nl

altLabel

MovementDisorder Society Task ...... scales for Parkinson's disease

@en

prefLabel

Movement Disorder Society Task ...... le: status and recommendations

@ast

Movement Disorder Society Task ...... le: status and recommendations

@en

Movement Disorder Society Task ...... le: status and recommendations

@nl

P1433

Q28282629-9E556A18-4673-4B66-AD62-62A3BDFCE000

P1476

Q28282629-969594C2-4F72-4303-88CF-86222C14A16F

Q28282629-FA48F514-C3C8-4A45-84A1-6F295F0FC257

P2093

Q28282629-1A1AA4A9-0CE2-4477-ACEE-46277E7F047D

Q28282629-465809E8-87D8-459A-855D-36FB9EBFFBBB

Q28282629-4B82CC35-B4BD-4D21-B6B2-7F0772364319

Q28282629-5868299A-73D8-4841-8A2B-664338079D5D

Q28282629-5E71D87C-F324-40A1-88E2-B8167725FE87

Q28282629-7C92C0E5-1789-4B04-8747-8A8F396AFD5A

Q28282629-C3E47022-A638-42EF-8FD0-DC53DD6355C8

Q28282629-C8EAA6C9-27A5-4A33-BCE3-10712B51F7E5

Q28282629-D9F03941-64A3-4EEC-89F9-EBA26BECD550

Q28282629-F39282FE-895F-41E7-A251-9A7304E9B3D5

P2860

Q28282629-10D64110-3707-4730-A8DB-3DF48224FDC8

Q28282629-1B93B588-C797-44AB-8835-D1AFCC55254C

Q28282629-A129D2BD-F2AD-451A-9FB7-486B03FEA76C

Q28282629-AE86C167-F36A-4107-8734-06D18BCAF229

Q28282629-E57C3320-41CE-4D91-8140-B67A0FFAFAB2

P304

Q28282629-162E6450-C217-423E-AC1A-524AE9CB27DC

Q28282629-387E3B73-14E7-4413-87D0-064F2F3F6BE8

P31

Q28282629-4D2F4C63-8CC4-4702-8A30-E032B582AB03

P3181

Q28282629-25AA22D6-6554-4830-9991-871EAF656FCC

P356

Q28282629-7369024C-D160-47F0-94F1-2D3D7D83EADD

P407

Q28282629-5FFD06F3-5F2D-4B2F-BB84-E572717ADCB8

P433

Q28282629-FC6EA71C-C74D-41F3-8120-CEE7E2355357

P478

Q28282629-B96E89B3-A451-4B5C-B727-582E3A9B73F5

P50

Q28282629-0268B5EF-E9CB-46E3-86C7-E976F44DC337

Q28282629-1642EC53-703B-44B9-918B-255FEDD4AE01

Q28282629-79EF2AE8-E13A-4F70-B6AA-F2FCF2088ACD

Q28282629-8646A96A-C487-4362-85A3-AAB8FE35845F

Q28282629-8F3A5D1C-C5EC-4518-AD0B-D68C886D3945

Q28282629-9D23A6DB-A5A3-4CAB-867A-B6DE50C7E970

Q28282629-DDFFDD14-88E2-4AB7-ABDB-645D8C184200

Q28282629-EBC6E194-E21A-4682-A9F7-96FD0E739C8F

P577

Q28282629-FA5C69A1-E40B-4CF7-8633-F325CC64E2AA

P5875

Q28282629-65331C07-2D81-4387-A80C-077B7D562AF3

P698

Q28282629-729C57D5-A51F-4427-BDEB-1FF8B8E58203

P921

Q28282629-98E8D23D-4828-488C-999C-0A154C2764C5

P3181

P356

P1433

Movement Disorders

P1476

Movement Disorder Society Task ...... le: status and recommendations

@en

MovementDisorder Society Task ...... scales for Parkinson's disease

@en

P2093

Carl Counsell

http://www.w3.org/2001/XMLSchema#string

Charity G. Moore

http://www.w3.org/2001/XMLSchema#string

Christopher G. Goetz

http://www.w3.org/2001/XMLSchema#string

Glenn T Stebbins

http://www.w3.org/2001/XMLSchema#string

Glenn T. Stebbins

http://www.w3.org/2001/XMLSchema#string

Lisa Seidl

http://www.w3.org/2001/XMLSchema#string

Melvin D Yahr

http://www.w3.org/2001/XMLSchema#string

Melvin D. Yahr

http://www.w3.org/2001/XMLSchema#string

Robert G Holloway

http://www.w3.org/2001/XMLSchema#string

Robert G. Holloway

http://www.w3.org/2001/XMLSchema#string

P2860

The natural history of Parkinson's disease.

Progression of Parkinson's disease without levodopa.

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.

Factor analysis of Parkinson's impairment. An evaluation of the final common pathway.

Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.

P304

1020-1028

http://www.w3.org/2001/XMLSchema#string

1020-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

64137

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/MDS.20213

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Cristina Sampaio

Charity G Moore

Christopher G. Goetz

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227635140

http://www.w3.org/2001/XMLSchema#string

P698

15372591

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease